Meiji Seika Is Latest To Kick Off Ustekinumab Phase III

Sees Positive Phase I Results For Stelara Biosimilar With Dong-A Socio Holdings

 
• By David Wallace
  
Starting blocks sprint race
Several companies are jostling for position on biosimilar Stelara • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products